Abstract
Undifferentiated spondyloarthropathies USPA can sometimes be refractory to usual disease modifying agents. Anti-tumor necrosis factor TNF-alpha agents have been shown to be effective in spondyloarthropathies. Few articles described the efficacy of TNF-alpha antagonists in USPA. Our patient had refractory Achilles tendonitis as an early manifestation of USPA which responded dramatically to infliximab treatment.
MeSH terms
-
Achilles Tendon / pathology*
-
Adult
-
Animals
-
Anti-Inflammatory Agents / pharmacology
-
Anti-Inflammatory Agents / therapeutic use*
-
Antibodies, Monoclonal / pharmacology
-
Antibodies, Monoclonal / therapeutic use*
-
Humans
-
Infliximab
-
Magnetic Resonance Imaging
-
Male
-
Tendinopathy / diagnosis
-
Tendinopathy / drug therapy*
-
Tumor Necrosis Factor-alpha / antagonists & inhibitors
Substances
-
Anti-Inflammatory Agents
-
Antibodies, Monoclonal
-
Tumor Necrosis Factor-alpha
-
Infliximab